Market Analysis and Insights: Global Cancer Immunotherapy Drug Discovery Outsourcing Market
The global Cancer Immunotherapy Drug Discovery Outsourcing market is projected to grow from US$ 1119.1 million in 2024 to US$ 2057.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 10.7% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Cancer Immunotherapy Drug Discovery Outsourcing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Cancer Immunotherapy Drug Discovery Outsourcing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cancer Immunotherapy Drug Discovery Outsourcing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cancer Immunotherapy Drug Discovery Outsourcing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cancer Immunotherapy Drug Discovery Outsourcing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cancer Immunotherapy Drug Discovery Outsourcing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Aquila BioMedical
BPS Bioscience, Inc.
Celentyx Ltd
Crown Bioscience, Inc.
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences Co.
Horizon Discovery Group PLC
ImmunXperts SA
Molecular Imaging, Inc.
Promega Corporation,Personalis, Inc.
STC Biologics
Segment by Type
By Drug Type
By Cancer Type
Segment by Application
Lung
Breast
Colorectal
Melanoma
Prostate
Head and Neck
Ovarian
Pancreatic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cancer Immunotherapy Drug Discovery Outsourcing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Immunotherapy Drug Discovery Outsourcing companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Immunotherapy Drug Discovery Outsourcing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 By Drug Type
1.2.3 By Cancer Type
1.3 Market by Application
1.3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Lung
1.3.3 Breast
1.3.4 Colorectal
1.3.5 Melanoma
1.3.6 Prostate
1.3.7 Head and Neck
1.3.8 Ovarian
1.3.9 Pancreatic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Perspective (2019-2030)
2.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Growth Trends by Region
2.2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Region (2019-2024)
2.2.3 Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Region (2025-2030)
2.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Dynamics
2.3.1 Cancer Immunotherapy Drug Discovery Outsourcing Industry Trends
2.3.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers
2.3.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Challenges
2.3.4 Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cancer Immunotherapy Drug Discovery Outsourcing by Players
3.1.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Players (2019-2024)
3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cancer Immunotherapy Drug Discovery Outsourcing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio
3.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2023
3.5 Global Key Players of Cancer Immunotherapy Drug Discovery Outsourcing Head office and Area Served
3.6 Global Key Players of Cancer Immunotherapy Drug Discovery Outsourcing, Product and Application
3.7 Global Key Players of Cancer Immunotherapy Drug Discovery Outsourcing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Immunotherapy Drug Discovery Outsourcing Breakdown Data by Type
4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Type (2019-2024)
4.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2025-2030)
5 Cancer Immunotherapy Drug Discovery Outsourcing Breakdown Data by Application
5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Application (2019-2024)
5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2019-2030)
6.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
6.2.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024)
6.2.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030)
6.2.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)
6.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
6.3.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024)
6.3.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030)
6.3.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)
6.4 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
6.4.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2019-2024)
6.4.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2019-2030)
7.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
7.2.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024)
7.2.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030)
7.2.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)
7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
7.3.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024)
7.3.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030)
7.3.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)
7.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
7.4.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2019-2024)
7.4.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2019-2030)
8.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
8.2.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024)
8.2.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030)
8.2.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)
8.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
8.3.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024)
8.3.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030)
8.3.3 China Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2019-2030)
9.2 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
9.2.1 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024)
9.2.2 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030)
9.2.3 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)
9.3 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
9.3.1 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024)
9.3.2 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030)
9.3.3 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)
9.4 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region
9.4.1 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2019-2024)
9.4.3 Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Aquila BioMedical
11.1.1 Aquila BioMedical Company Details
11.1.2 Aquila BioMedical Business Overview
11.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.1.4 Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)
11.1.5 Aquila BioMedical Recent Developments
11.2 BPS Bioscience, Inc.
11.2.1 BPS Bioscience, Inc. Company Details
11.2.2 BPS Bioscience, Inc. Business Overview
11.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.2.4 BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)
11.2.5 BPS Bioscience, Inc. Recent Developments
11.3 Celentyx Ltd
11.3.1 Celentyx Ltd Company Details
11.3.2 Celentyx Ltd Business Overview
11.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.3.4 Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)
11.3.5 Celentyx Ltd Recent Developments
11.4 Crown Bioscience, Inc.
11.4.1 Crown Bioscience, Inc. Company Details
11.4.2 Crown Bioscience, Inc. Business Overview
11.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.4.4 Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)
11.4.5 Crown Bioscience, Inc. Recent Developments
11.5 DiscoverX Corporation
11.5.1 DiscoverX Corporation Company Details
11.5.2 DiscoverX Corporation Business Overview
11.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.5.4 DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)
11.5.5 DiscoverX Corporation Recent Developments
11.6 Explicyte
11.6.1 Explicyte Company Details
11.6.2 Explicyte Business Overview
11.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.6.4 Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)
11.6.5 Explicyte Recent Developments
11.7 Genscript Biotech Corporation
11.7.1 Genscript Biotech Corporation Company Details
11.7.2 Genscript Biotech Corporation Business Overview
11.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.7.4 Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)
11.7.5 Genscript Biotech Corporation Recent Developments
11.8 HD Biosciences Co.
11.8.1 HD Biosciences Co. Company Details
11.8.2 HD Biosciences Co. Business Overview
11.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.8.4 HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)
11.8.5 HD Biosciences Co. Recent Developments
11.9 Horizon Discovery Group PLC
11.9.1 Horizon Discovery Group PLC Company Details
11.9.2 Horizon Discovery Group PLC Business Overview
11.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.9.4 Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)
11.9.5 Horizon Discovery Group PLC Recent Developments
11.10 ImmunXperts SA
11.10.1 ImmunXperts SA Company Details
11.10.2 ImmunXperts SA Business Overview
11.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.10.4 ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)
11.10.5 ImmunXperts SA Recent Developments
11.11 Molecular Imaging, Inc.
11.11.1 Molecular Imaging, Inc. Company Details
11.11.2 Molecular Imaging, Inc. Business Overview
11.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.11.4 Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)
11.11.5 Molecular Imaging, Inc. Recent Developments
11.12 Promega Corporation,Personalis, Inc.
11.12.1 Promega Corporation,Personalis, Inc. Company Details
11.12.2 Promega Corporation,Personalis, Inc. Business Overview
11.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.12.4 Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)
11.12.5 Promega Corporation,Personalis, Inc. Recent Developments
11.13 STC Biologics
11.13.1 STC Biologics Company Details
11.13.2 STC Biologics Business Overview
11.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.13.4 STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2019-2024)
11.13.5 STC Biologics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Aquila BioMedical
BPS Bioscience, Inc.
Celentyx Ltd
Crown Bioscience, Inc.
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences Co.
Horizon Discovery Group PLC
ImmunXperts SA
Molecular Imaging, Inc.
Promega Corporation,Personalis, Inc.
STC Biologics
听
听
*If Applicable.